Abstracting and Indexing
Web Site of Urooncology Association
E-ISSN: 2667-4610
About Us
Journal History
Aims and Scope
Abstracting and Indexing
Editorial Board
Recruitment of Editors
Roles and Responsibilities
Editorial Board
Journal Policies
Advertising
Allegations of Misconduct
Appeals and Complaints
Archiving and Preservation
Article Processing Charges (APC)
Artificial Intelligence (AI)
Authorship and Contributorship
Conflicts of Interest
Copyright and Licensing
Data Availability and Reproducibility
Diversity, Equity, Inclusion, and Accessibility (DEIA)
Editorial Oversight
Ethical Misconduct
Open Access
Peer Review Policy
Post Publication Discussions
Research Ethics
Instructions to Authors
Instructions to Authors
Instructions for Reviewers
Ethical Policy
Peer Review Process
Contact Us
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
PDF
Cite
Share
Request
Review
VOLUME: 16 ISSUE: 1
P: 22 - 27
March 2017
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
Bull Urooncol 2017;16(1):22-27
DOI:
10.4274/uob.606
Dr. Ece Konaç
1
Dr. Sinan Sözen
2
Author Information
Copyright & Licence Information
Galenos & Bull Urooncol Disclaimer
1.
Gazi Üniversitesi Tip Fakültesi, Tibbi Biyoloji Ve Genetik Anabilim Dali, Ankara, Türkiye
2.
Gazi Üniversitesi Tip Fakültesi, Üroloji Anabilim Dali, Ankara, Türkiye
No information available.
No information available
Received Date:
06.01.2016
Accepted Date:
02.02.2016
PDF
Cite
Share
Request
Keywords:
Apoptosis, anti-chaperone agents, treatment resistance, prostate cancer
